ENO1 and pancreatic neoplasm: Linc-UROD can prevent ENO1 and PKM from being degraded by proteasome by reducing the ubiquitination of ENO1 and PKM proteins, and finally enhance the glycolysis and invasion ability of pancreatic cancer [143].